In Vitro Coagulation Effects of Ophthalmic Doses of Bevacizumab
Journal of Ocular Pharmacology and Therapeutics, 06/01/2012
Clinical Article
Li E et al. – A common ophthalmic dose of bevacizumab 1.25 mg significantly increased in vitro coagulation.



